Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain

被引:18
|
作者
Shannon, A. E. [1 ]
Chappell, K. J. [1 ]
Stoermer, M. J. [2 ]
Chow, S. Y. [2 ]
Kok, W. M. [2 ]
Fairlie, D. P. [2 ]
Young, P. R. [1 ,2 ]
机构
[1] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld 4072, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
Dengue virus; Protease; NS2B-NS3; Cofactor inhibitor; YELLOW-FEVER VIRUS; WEST-NILE-VIRUS; ENZYMATIC CHARACTERIZATION; STRUCTURAL PROTEINS; VIRAL REPLICATION; CLEAVAGE SITES; IN-VITRO; POLYPROTEIN; MUTAGENESIS; FLAVIVIRUS;
D O I
10.1016/j.pep.2015.11.022
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Dengue Virus (DENV) infection is responsible for the world's most significant insect-borne viral disease. Despite an increasing global impact, there are neither prophylactic nor therapeutic options available for the effective treatment of DENV infection. An attractive target for antiviral drugs is the virally encoded trypsin-like serine protease (NS3pro) and its associated cofactor (NS2B). The NS2B NS3pro complex is responsible for cleaving the viral polyprotein into separate functional viral proteins, and is therefore essential for replication. Recombinant expression of an active NS2B-NS3 protease has primarily been based on constructs linking the C-terminus of the approximately 40 amino acid hydrophilic cofactor domain of NS2B to the N-terminus of NS3pro via a flexible glycine linker. The resulting complex can be expressed in high yield, is soluble and catalytically active and has been used for most in vitro screening, inhibitor, and X-ray crystallographic studies over the last 15 years. Despite extensive analysis, no inhibitor drug candidates have been identified yet. Moreover, the effect of the artificial linker introduced between the protease and its cofactor is unknown. Two alternate methods for bacterial expression of non-covalently linked, catalytically active, NS2B-NS3pro complex are described here along with a comparison of the kinetics of substrate proteolysis and binding affinities of substrate-based aldehyde inhibitors. Both expression methods produced high yields of soluble protein with improved substrate proteolysis kinetics and inhibitor binding compared to their glycine-linked equivalent. The non-covalent association between NS2B and NS3pro is predicted to be more relevant for examining inhibitors that target cofactor-protease interactions rather than the protease active site. Furthermore, these approaches offer alternative strategies for the high yield co-expression of other protein assemblies. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 50 条
  • [11] Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease
    Liu, Hailong
    Wu, Ruoming
    Sun, Yanyan
    Ye, Yan
    Chen, Jing
    Luo, Xiaomin
    Shen, Xu
    Liu, Hong
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (22) : 6344 - 6352
  • [12] Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation
    Niyomrattanakit, P
    Winoyanuwattikun, P
    Chanprapaph, S
    Angsuthanasombat, C
    Panyim, S
    Katzenmeier, G
    JOURNAL OF VIROLOGY, 2004, 78 (24) : 13708 - 13716
  • [13] Phosphonate inhibitors of West Nile virus NS2B/NS3 protease
    Skorenski, Marcin
    Milewska, Aleksandra
    Pyrc, Krzysztof
    Sienczyk, Marcin
    Oleksyszyn, Jozef
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 8 - 14
  • [14] DENGUE-2 VIRUS NS2B AND NS3 FORM A STABLE COMPLEX THAT CAN CLEAVE NS3 WITHIN THE HELICASE DOMAIN
    ARIAS, CF
    PREUGSCHAT, F
    STRAUSS, JH
    VIROLOGY, 1993, 193 (02) : 888 - 899
  • [15] West Nile Virus NS2B/NS3 Protease As An Antiviral Target
    Chappell, K. J.
    Stoermer, M. J.
    Fairlie, D. P.
    Young, P. R.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (27) : 2771 - 2784
  • [16] The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection
    Starvaggi, Jose
    Previti, Santo
    Zappala, Maria
    Ettari, Roberta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [17] In-silico Design of Curcumin Analogs as Potential Inhibitors of Dengue Virus NS2B/NS3 Protease
    Roney, Miah
    Huq, A. K. M. Moyeenul
    Aluwi, Mohd Fadhlizil Fasihi Mohd
    Tajuddin, Saiful Nizam
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2023, : 645 - 653
  • [18] Molecular modeling studies on dengue and West Nile Virus NS2B/NS3 protease inhibitor interaction
    K Wichapong
    S Pianwanit
    S Kokpol
    W Sippl
    Chemistry Central Journal, 3 (Suppl 1)
  • [19] Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor
    Brinkworth, RI
    Fairlie, DP
    Leung, D
    Young, PR
    JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 1167 - 1177
  • [20] Zika Virus Targeting by Screening Inhibitors against NS2B/NS3 Protease
    Choudhry, Hani
    Alzahrani, Faisal A.
    Hassan, Mohammed A.
    Alghamdi, Asma
    Abdulaal, Wesam H.
    Bakhrebah, Muhammed A.
    Zamzami, Mazin A.
    Helmi, Nawal
    Bokhari, Fawzi F.
    Zeyadi, Mustafa
    Baothman, Othman A.
    Kamal, Mohammad A.
    Warsi, Mohiuddin K.
    Ali, Ashraf
    Jarullah, Bushra
    Jamal, Mohammad S.
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019